A detailed history of Nemes Rush Group LLC transactions in Amgen Inc stock. As of the latest transaction made, Nemes Rush Group LLC holds 643 shares of AMGN stock, worth $213,765. This represents 0.03% of its overall portfolio holdings.

Number of Shares
643
Previous 1,167 44.9%
Holding current value
$213,765
Previous $332 Million 39.45%
% of portfolio
0.03%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$262.75 - $319.31 $137,681 - $167,318
-524 Reduced 44.9%
643 $201 Million
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $716,269 - $864,627
-2,664 Reduced 69.54%
1,167 $332 Million
Q4 2023

Feb 09, 2024

SELL
$255.7 - $288.46 $3,579 - $4,038
-14 Reduced 0.36%
3,831 $1.1 Billion
Q3 2023

Nov 09, 2023

BUY
$218.65 - $271.46 $5,684 - $7,057
26 Added 0.68%
3,845 $1.03 Billion
Q2 2023

Aug 02, 2023

BUY
$214.27 - $253.37 $818,297 - $967,620
3,819 New
3,819 $848 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $178B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Nemes Rush Group LLC Portfolio

Follow Nemes Rush Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nemes Rush Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nemes Rush Group LLC with notifications on news.